Phreesia, Inc. (NYSE:PHR) shares were trading more than 15% lower Thursday morning following the company’s reported mixed Q3 results, with EPS coming in at ($0.71), worse than the Street estimate of ($0.47). Quarterly revenue was $55.92 million, beating the consensus estimate by 15.19%.

Adjusted EBITDA fell short of consensus as the company continues to ramp investments across the business, which management plans to accelerate in Q4 and again in 2023.

The company also raised full 2022 revenue guidance to $211 million (vs. Street’s $198 million), debuted EBITDA guidance of -$64 million (vs. Street’s -$35 million), and provided a 20-25% growth target for 2023.